Nestor Arita, MD
Vascular Surgery · Mountain Home, ARNPI 1124438072
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (51.3%), travel and lodging and education — rather than concentrated in one kind of arrangement. It is spread thinly across 28 manufacturers, the largest accounting for just 20.2%.
Across 187 payments — averaging $103.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- W. L. Gore & Associates, Inc.$4K
- Silk Road Medical, Inc.$3K
- Penumbra, Inc.$3K
- Endologix LLC$3K
- Abbott$2K
- Bolton Medical Inc$2K
- plus $4K from 22 others
What the payments were for
- Travel & lodging$9,07647%
- Food & beverage$9,93151%
- Education$3542%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| W. L. Gore & Associates, Inc. | 32 | $3,904 |
| Silk Road Medical, Inc. | 19 | $3,033 |
| Penumbra, Inc. | 8 | $2,787 |
| Endologix LLC | 15 | $2,505 |
| Abbott | 13 | $1,698 |
| Bolton Medical Inc | 24 | $1,691 |
| Medtronic(2 entities) | 13 | $1,196 |
| Stryker | 4 | $860 |
| Cook Medical LLC | 8 | $379 |
| AbbVie | 17 | $199 |
| Boston Scientific | 3 | $163 |
| Asahi Intecc USA, Inc. | 5 | $140 |
| Shockwave Medical, Inc | 1 | $116 |
| AstraZeneca(2 entities) | 6 | $113 |
| Globus Medical | 2 | $98 |
| Cvrx, Inc. | 1 | $92 |
| KCI USA, Inc. | 1 | $84 |
| Lemaitre Vascular, Inc. | 3 | $45 |
| Abiomed | 1 | $37 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $36 |
| Elutia, Inc. | 2 | $35 |
| Philips North America LLC | 1 | $33 |
| Merck | 1 | $21 |
| TELA Bio, Inc. | 1 | $21 |
| Surmodics, Inc. | 1 | $20 |
| Tactile Systems Technology Inc | 1 | $19 |
| Endogastric Solutions, Inc | 1 | $19 |
| Johnson & Johnson | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ENROUTE Transcarotid Neuroprotection System$3,848
- ENROUTE Transcarotid Stent$2,575
- RUBY Coil$1,965
- ENDOCROSS Device$1,257
- Torus Stent Graft System$1,257
- XACT$1,172
- ENROUTE Enflate Transcarotid RX Balloon Dilatation Catheter$1,135
- GORE TAG Thoracic Endoprosthesis$1,035
- EXCLUDER AAA Endoprosthesis$867
- Indigo System$679
- CLOTTRIEVER BOLD CATHETER$611
- Ovation iX Iliac Stent Graft$498
- AFX2 Bifurcated Endograft System$498
- Grafts$430
- TAG Thoracic Endoprosthesis$400
- TurboHawk$376
- TREO ABDOMINAL STENT-GRAFT SYSTEM$331
- ENDURANT IIS$297
- Alto Abdominal Stent Graft System$276
- Vascular Graft$259
How this compares
Too few vascular surgery providers in Arkansasto place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XareltoRivaroxaban | 16 | $11,832 |
| EliquisApixaban | 12 | $6,788 |
| ClopidogrelClopidogrel Bisulfate | 40 | $345 |
| Cilostazol | 20 | $229 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 13 | $169 |
| Atorvastatin Calcium | 18 | $140 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 35 | $115 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonXarelto | $17 | $11,83216 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. There are too few vascular surgery providers in Arkansason file to place this against a meaningful peer group, so we don't.
Other vascular surgery in Mountain Home
- Christopher StoutRogers$333K
- Mohammed MoursiLittle Rock$116K
- Matthew HendrichJonesboro$41K
- Mark WrightJonesboro$28K
- Heather LeblancPine Bluff$16K
- Kalenda KasanganaLittle Rock$15K
- Kyla Shelton LangLittle Rock$14K
- Andre RamdonLittle Rock$10K
- Lauren Story-HeftaLittle Rock$9K
- Christian SimmonsLittle Rock$8K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.